Stephen S. Yoder

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

PVLA

Current role

CEO, Board Member

2023-06-21–present

1 call Latest call 2026-08-04

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Palvella Therapeutics, Inc. (PVLA)	Chief Executive Officer	$584,595	$146,149	—	$614,818	—	$13,390	$1,358,952
2022	Palvella Therapeutics, Inc. (PVLA)	Chief Executive Officer	$564,826	—	—	$1,288,128	$197,689	$12,200	$2,062,843
2021	Palvella Therapeutics, Inc. (PVLA)	Chief Executive Officer	$548,375	—	—	$858,754	$274,188	$11,600	$1,692,917
2020	Palvella Therapeutics, Inc. (PVLA)	Chief Executive Officer	$535,000	—	—	$808,699	$173,875	$21,255	$1,538,829
2019	Palvella Therapeutics, Inc. (PVLA)	Chief Executive Officer	$515,000	—	—	$815,670	$208,575	$54,353	$1,593,598
2018	Palvella Therapeutics, Inc. (PVLA)	Chief Executive Officer	$500,000	—	—	$1,866,366	$212,500	$42,142	$2,621,008

Earnings-call appearances and filed executive appointments or departures, newest first.